table of content
1 Introduction to Research & Analysis Reports
1.1 Neurological Disorder Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neurological Disorder Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neurological Disorder Drugs Overall Market Size
2.1 Global Neurological Disorder Drugs Market Size: 2023 VS 2030
2.2 Global Neurological Disorder Drugs Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neurological Disorder Drugs Players in Global Market
3.2 Top Global Neurological Disorder Drugs Companies Ranked by Revenue
3.3 Global Neurological Disorder Drugs Revenue by Companies
3.4 Top 3 and Top 5 Neurological Disorder Drugs Companies in Global Market, by Revenue in 2023
3.5 Global Companies Neurological Disorder Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neurological Disorder Drugs Players in Global Market
3.6.1 List of Global Tier 1 Neurological Disorder Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Neurological Disorder Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neurological Disorder Drugs Market Size Markets, 2023 & 2030
4.1.2 Antipsychotic
4.1.3 Hypnotic & Sedative
4.1.4 Analgesics
4.1.5 Anticoagulants
4.1.6 Others
4.2 By Type - Global Neurological Disorder Drugs Revenue & Forecasts
4.2.1 By Type - Global Neurological Disorder Drugs Revenue, 2019-2024
4.2.2 By Type - Global Neurological Disorder Drugs Revenue, 2025-2030
4.2.3 By Type - Global Neurological Disorder Drugs Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neurological Disorder Drugs Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Neurological Disorder Drugs Revenue & Forecasts
5.2.1 By Application - Global Neurological Disorder Drugs Revenue, 2019-2024
5.2.2 By Application - Global Neurological Disorder Drugs Revenue, 2025-2030
5.2.3 By Application - Global Neurological Disorder Drugs Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Neurological Disorder Drugs Market Size, 2023 & 2030
6.2 By Region - Global Neurological Disorder Drugs Revenue & Forecasts
6.2.1 By Region - Global Neurological Disorder Drugs Revenue, 2019-2024
6.2.2 By Region - Global Neurological Disorder Drugs Revenue, 2025-2030
6.2.3 By Region - Global Neurological Disorder Drugs Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Neurological Disorder Drugs Revenue, 2019-2030
6.3.2 US Neurological Disorder Drugs Market Size, 2019-2030
6.3.3 Canada Neurological Disorder Drugs Market Size, 2019-2030
6.3.4 Mexico Neurological Disorder Drugs Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Neurological Disorder Drugs Revenue, 2019-2030
6.4.2 Germany Neurological Disorder Drugs Market Size, 2019-2030
6.4.3 France Neurological Disorder Drugs Market Size, 2019-2030
6.4.4 U.K. Neurological Disorder Drugs Market Size, 2019-2030
6.4.5 Italy Neurological Disorder Drugs Market Size, 2019-2030
6.4.6 Russia Neurological Disorder Drugs Market Size, 2019-2030
6.4.7 Nordic Countries Neurological Disorder Drugs Market Size, 2019-2030
6.4.8 Benelux Neurological Disorder Drugs Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Neurological Disorder Drugs Revenue, 2019-2030
6.5.2 China Neurological Disorder Drugs Market Size, 2019-2030
6.5.3 Japan Neurological Disorder Drugs Market Size, 2019-2030
6.5.4 South Korea Neurological Disorder Drugs Market Size, 2019-2030
6.5.5 Southeast Asia Neurological Disorder Drugs Market Size, 2019-2030
6.5.6 India Neurological Disorder Drugs Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Neurological Disorder Drugs Revenue, 2019-2030
6.6.2 Brazil Neurological Disorder Drugs Market Size, 2019-2030
6.6.3 Argentina Neurological Disorder Drugs Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neurological Disorder Drugs Revenue, 2019-2030
6.7.2 Turkey Neurological Disorder Drugs Market Size, 2019-2030
6.7.3 Israel Neurological Disorder Drugs Market Size, 2019-2030
6.7.4 Saudi Arabia Neurological Disorder Drugs Market Size, 2019-2030
6.7.5 UAE Neurological Disorder Drugs Market Size, 2019-2030
7 Neurological Disorder Drugs Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Neurological Disorder Drugs Major Product Offerings
7.1.4 Novartis Neurological Disorder Drugs Revenue in Global Market (2019-2024)
7.1.5 Novartis Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Neurological Disorder Drugs Major Product Offerings
7.2.4 GlaxoSmithKline Neurological Disorder Drugs Revenue in Global Market (2019-2024)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Merck & Co.
7.3.1 Merck & Co. Company Summary
7.3.2 Merck & Co. Business Overview
7.3.3 Merck & Co. Neurological Disorder Drugs Major Product Offerings
7.3.4 Merck & Co. Neurological Disorder Drugs Revenue in Global Market (2019-2024)
7.3.5 Merck & Co. Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Neurological Disorder Drugs Major Product Offerings
7.4.4 Bayer Neurological Disorder Drugs Revenue in Global Market (2019-2024)
7.4.5 Bayer Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Neurological Disorder Drugs Major Product Offerings
7.5.4 AstraZeneca Neurological Disorder Drugs Revenue in Global Market (2019-2024)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Neurological Disorder Drugs Major Product Offerings
7.6.4 Boehringer Ingelheim Neurological Disorder Drugs Revenue in Global Market (2019-2024)
7.6.5 Boehringer Ingelheim Key News & Latest Developments
7.7 Teva Pharmaceutical
7.7.1 Teva Pharmaceutical Company Summary
7.7.2 Teva Pharmaceutical Business Overview
7.7.3 Teva Pharmaceutical Neurological Disorder Drugs Major Product Offerings
7.7.4 Teva Pharmaceutical Neurological Disorder Drugs Revenue in Global Market (2019-2024)
7.7.5 Teva Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
